331 related articles for article (PubMed ID: 18728938)
41. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
[TBL] [Abstract][Full Text] [Related]
42. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
[TBL] [Abstract][Full Text] [Related]
43. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
Motohashi H; Inui K
AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
[TBL] [Abstract][Full Text] [Related]
44. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP.
Schlatter E; Mönnich V; Cetinkaya I; Mehrens T; Ciarimboli G; Hirsch JR; Popp C; Koepsell H
J Membr Biol; 2002 Oct; 189(3):237-44. PubMed ID: 12395288
[TBL] [Abstract][Full Text] [Related]
45. Effect of high uric acid on the disposition of metformin: in vivo and in vitro studies.
Zhang G; Ma Y; Xi D; Rao Z; Sun X; Wu X
Biopharm Drug Dispos; 2019 Jan; 40(1):3-11. PubMed ID: 30488476
[TBL] [Abstract][Full Text] [Related]
46. A PET Tracer for Renal Organic Cation Transporters, ¹¹C-Metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
Jakobsen S; Busk M; Jensen JB; Munk OL; Zois NE; Alstrup AK; Jessen N; Frøkiær J
J Nucl Med; 2016 Apr; 57(4):615-21. PubMed ID: 26769859
[TBL] [Abstract][Full Text] [Related]
47. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
[TBL] [Abstract][Full Text] [Related]
48. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
[TBL] [Abstract][Full Text] [Related]
49. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
[TBL] [Abstract][Full Text] [Related]
50. Genetic variants of the organic cation transporter 2 influence the disposition of metformin.
Song IS; Shin HJ; Shim EJ; Jung IS; Kim WY; Shon JH; Shin JG
Clin Pharmacol Ther; 2008 Nov; 84(5):559-62. PubMed ID: 18401339
[TBL] [Abstract][Full Text] [Related]
51. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Harper JN; Wright SH
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F56-67. PubMed ID: 23034939
[TBL] [Abstract][Full Text] [Related]
52. OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine.
Wang ZJ; Yin OQ; Tomlinson B; Chow MS
Pharmacogenet Genomics; 2008 Jul; 18(7):637-45. PubMed ID: 18551044
[TBL] [Abstract][Full Text] [Related]
53. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
54. Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.
Ciarimboli G; Lancaster CS; Schlatter E; Franke RM; Sprowl JA; Pavenstädt H; Massmann V; Guckel D; Mathijssen RH; Yang W; Pui CH; Relling MV; Herrmann E; Sparreboom A
Clin Cancer Res; 2012 Feb; 18(4):1101-8. PubMed ID: 22223530
[TBL] [Abstract][Full Text] [Related]
55. Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule.
Kaewmokul S; Chatsudthipong V; Evans KK; Dantzler WH; Wright SH
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1149-59. PubMed ID: 12944320
[TBL] [Abstract][Full Text] [Related]
56. Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.
Severance AC; Sandoval PJ; Wright SH
J Pharmacol Exp Ther; 2017 Sep; 362(3):405-412. PubMed ID: 28615288
[TBL] [Abstract][Full Text] [Related]
57. An in vitro study on interaction of anisodine and monocrotaline with organic cation transporters of the SLC22 and SLC47 families.
Chen JY; Brockmöller J; Tzvetkov MV; Wang LJ; Chen XJ
Chin J Nat Med; 2019 Jul; 17(7):490-497. PubMed ID: 31514980
[TBL] [Abstract][Full Text] [Related]
58. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.
Fujita T; Urban TJ; Leabman MK; Fujita K; Giacomini KM
J Pharm Sci; 2006 Jan; 95(1):25-36. PubMed ID: 16307453
[TBL] [Abstract][Full Text] [Related]
59. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
[TBL] [Abstract][Full Text] [Related]
60. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
